Clinical Trial Update: The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of oral dipyridamole on the innate immune response in humans with endotoxemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endotoxemia | Phase 4 | Status: COMPLETED